Compulsory licensure: The case of cipro and beyond

American Journal of Bioethics

Volumn 2, Issue 3, 2002, Pages 40-

  Chakrabarty, Ananda M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DRUG;

ANTHRAX; BIOLOGICAL WARFARE; DRUG INDUSTRY; ECONOMICS; EMBRYO RESEARCH; GOVERNMENT; HEALTH CARE AND PUBLIC HEALTH; HUMAN; INTERNATIONAL COOPERATION; LEGAL APPROACH; LEGAL ASPECT; LICENSING; NOTE; PATENT; POLICY; STEM CELL; UNITED STATES;

HEALTH CARE AND PUBLIC HEALTH; LEGAL APPROACH;

ANTHRAX; BIOTERRORISM; CIPROFLOXACIN; DRUG INDUSTRY; EMBRYO RESEARCH; FEDERAL GOVERNMENT; HUMANS; INTERNATIONALITY; LICENSURE; PATENTS; PHARMACEUTICAL PREPARATIONS; PUBLIC POLICY; STEM CELLS; UNITED STATES;

EID: 18744366354     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651602760250093     Document Type: Note

References (1)

1. Resnik, D. B., and K. A. De Ville. 2002. Bioterrorism and patent rights: "Compulsory licensure" and the case of Cipro. The American Journal of Bioethics 2(3):29-39.